World Vaccine Adjuvants Market to See Further Growth

The world market for vaccine adjuvants is likely to amount to USD 769.4 million by 2021.

London, United Kingdom, July 02, 2016 --( TD The Market Publishers, Ltd. is pleased to inform that a new research report analysing the global vaccine adjuvants market can now be found in its online catalogue at

Worldwide, the market for vaccine adjuvants is forecast to amount to the USD 769.4 million mark by 2021, witnessing a healthy 10.5% CAGR. Amid the main factors boosting the growth of the sector include an increase in government spend on medical research, rising prevalence rates of diseases, growing biopharma & biotech industries, and surging focus on better vaccination.

As regard to product types, particulate adjuvants will likely grab the majority share of the total market by 2016, which is largely owing to the growing investments in research.

The intramuscular injection is the most widely used route of administration and is set to retain its dominant market share throughout 2016. Soaring prevalence of various diseases and the demand for novel vaccine adjuvants with improved efficacy are anticipated to stimulate the market growth.

North America is the biggest geographical market for vaccine adjuvants primarily due to the rise of the elderly population and a surge in government funding across the countries of the region.

TD The Market Publishers, Ltd
Natalie Aster
+44 208 144 6009